There were no statistically significant GO terms that distinguished FOXP2-positive versus FOXP2-negative GCB-DLBCL cases, and no GO terms from the upregulated gene lists (i.e. positively-associated with FOXP2 expression) that distinguished FOXP2-positive versus FOXP2-negative DLBCL or ABC-DLBCL cases. This evidence concerns the gene FOXP2 and diffuse large B-cell lymphoma.